1. Home
  2. WTFC vs ROIV Comparison

WTFC vs ROIV Comparison

Compare WTFC & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wintrust Financial Corporation

WTFC

Wintrust Financial Corporation

HOLD

Current Price

$154.08

Market Cap

9.9B

Sector

Finance

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$22.97

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WTFC
ROIV
Founded
1991
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9B
14.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WTFC
ROIV
Price
$154.08
$22.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
8
Target Price
$156.00
$24.31
AVG Volume (30 Days)
448.6K
6.7M
Earning Date
01-20-2026
02-09-2026
Dividend Yield
1.38%
N/A
EPS Growth
10.57
N/A
EPS
11.40
N/A
Revenue
$2,630,439,000.00
$20,329,000.00
Revenue This Year
$17.89
N/A
Revenue Next Year
$6.07
$741.42
P/E Ratio
$12.69
N/A
Revenue Growth
12.03
N/A
52 Week Low
$89.10
$8.73
52 Week High
$149.79
$23.91

Technical Indicators

Market Signals
Indicator
WTFC
ROIV
Relative Strength Index (RSI) 69.54 58.42
Support Level $144.29 $22.15
Resistance Level $148.60 $23.91
Average True Range (ATR) 3.66 0.72
MACD 0.19 0.04
Stochastic Oscillator 85.66 68.52

Price Performance

Historical Comparison
WTFC
ROIV

About WTFC Wintrust Financial Corporation

Wintrust Financial Corp is a financial holding company that provides community-oriented, personal, and commercial banking services to customers generally located in the Chicago metropolitan area, southern Wisconsin, northwest Indiana, and western Michigan. The company provides specialty finance services, including financing for the payment of property and casualty insurance premiums and life insurance premiums, and wealth management services to customers in its market area. The company's operations consist of three primary segments: community banking, specialty finance, and wealth management. The company generates the majority of its revenue from the community banking segment.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: